MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

AMCOL Health & Beauty Solutions, Inc

AMCOL Health & Beauty Solutions, Inc
AMCOL Health & Beauty Solutions, Inc develops and manufactures leading products for the dermatology field using its proprietary formulations and delivery systems; Microsponge and Poly-Pore.

The company in detail

Profile

AMCOL Health & Beauty Solutions, Inc (HBS) is the wholly owned subsidiary of AMCOL International Corporation. Founded in 2001, as a supplier of ingredients to the personal care industry, HBS has evolved to be one of the largest topical delivery system companies in the world, and a specialty supplier of "technology solutions" to the cosmetic, personal care, dermo-cosmetic, and dermatology fields. Through using its proprietary formulations and patented microparticle delivery system technologies, the company improves the efficacy, tolerability, and aesthetics of therapies ranging from acne to topical analgesic to hyperpigmentation/melasma. Because of its proprietary technologies, HBS' clients are assured of having novel, defensable and effective products.

With over 150 active clients around the world, HBS' clients range from Fortune 100 cosmetic and pharmaceutical companies to start-up dermocosmetic companies.

 

Partnering strategy/interests

HBS has crafted its capabilities to give the company the flexibility to meet the diverse needs of the varied markets its services and clients of all sizes ranging from start-ups to fortune 100 companies. Having the ability to both develop and manufacture topical products allows the company to provide a range of services including analytical methods development, formulation development including perfoming selected in-vitro studies internally, and the design and oversight of in-vivo studies, and the supply of products ranging from pre-clinical quantites to commercial scale production.

Further, the company has specifically stayed away from providing clincial services to allow it to freely collaborate with the leading clinical laboratories through the world.

Out-licensing

Application of microparticle delivery systems to enhance the performance of topical and transdermal formulations. More
Multiple OTC acne product forms More
Clinically proven, commercial formulations for both prescription and over the counter sales. More

Press Releases

(26th Feb 2009) Visit the Academy of Dermatology 67th Annual Meeting to meet Amcol HBS. More
(18th Aug 2008) ARLINGTON HEIGHTS, IL (August 18, 2008) — AMCOL HBS, a recognized leader in skin care technology and dermatology products, has introduced Skin Brightening Complex, a hydroquinone-free skin rejuvenation therapy developed to return health and radiance More
More press releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us